[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (67,020)

Search Parameters:
Keywords = surgery

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
16 pages, 11235 KiB  
Article
Surface Pre-Reacted Glass-Ionomer Eluate Suppresses Osteoclastogenesis through Downregulation of the MAPK Signaling Pathway
by Janaki Chandra, Shin Nakamura, Satoru Shindo, Elizabeth Leon, Maria Castellon, Maria Rita Pastore, Alireza Heidari, Lukasz Witek, Paulo G. Coelho, Toshiyuki Nakatsuka and Toshihisa Kawai
Biomedicines 2024, 12(8), 1835; https://doi.org/10.3390/biomedicines12081835 (registering DOI) - 12 Aug 2024
Abstract
Surface pre-reacted glass-ionomer (S-PRG) is a new bioactive filler utilized for the restoration of decayed teeth by its ability to release six bioactive ions that prevent the adhesion of dental plaque to the tooth surface. Since ionic liquids are reported to facilitate transepithelial [...] Read more.
Surface pre-reacted glass-ionomer (S-PRG) is a new bioactive filler utilized for the restoration of decayed teeth by its ability to release six bioactive ions that prevent the adhesion of dental plaque to the tooth surface. Since ionic liquids are reported to facilitate transepithelial penetration, we reasoned that S-PRG applied to root caries could impact the osteoclasts (OCs) in the proximal alveolar bone. Therefore, this study aimed to investigate the effect of S-PRG eluate solution on RANKL-induced OC-genesis and mineral dissolution in vitro. Using RAW264.7 cells as OC precursor cells (OPCs), TRAP staining and pit formation assays were conducted to monitor OC-genesis and mineral dissolution, respectively, while OC-genesis-associated gene expression was measured using quantitative real-time PCR (qPCR). Expression of NFATc1, a master regulator of OC differentiation, and the phosphorylation of MAPK signaling molecules were measured using Western blotting. S-PRG eluate dilutions at 1/200 and 1/400 showed no cytotoxicity to RAW264.7 cells but did significantly suppress both OC-genesis and mineral dissolution. The same concentrations of S-PRG eluate downregulated the RANKL-mediated induction of OCSTAMP and CATK mRNAs, as well as the expression of NFATc1 protein and the phosphorylation of ERK, JNK, and p38. These results demonstrate that S-PRG eluate can downregulate RANKL-induced OC-genesis and mineral dissolution, suggesting that its application to root caries might prevent alveolar bone resorption. Full article
(This article belongs to the Special Issue Osteoclast and Osteoblast: Current Status and Future Prospects)
Show Figures

Figure 1

Figure 1
<p>Timeline for release assay. S-PRG eluate was applied to HA-coated plate for 24 h. Fresh media were added to the wells, and the supernatant was collected at different time points. Collected supernatant was applied to OC-genesis assay.</p>
Full article ">Figure 2
<p>Cytotoxicity of S-PRG eluate. S-PRG eluate had no cytotoxic effect on RAW264.7 cells after diluting to more than 1/200. The horizontal dashed line with a value of 100 indicates the survival rate of RAW264.7 cells cultured in the absence of S-PRG eluate. Results were presented as the means ± SD. *: <span class="html-italic">p</span> &lt; 0.05, vs. control without S-PRG eluate.</p>
Full article ">Figure 3
<p>Evaluation of OC-genesis. The number of TRAP-positive cells by adding S-PRG eluate to osteoclast precursors (<b>A</b>,<b>B</b>). Quantification of pit area when adding S-PRG eluate. S-PRG eluate significantly decreased pit area created by osteoclasts compared to control (<b>C</b>,<b>D</b>). Scale bars indicate 100 µm. Results were presented as the means ± SD. *: <span class="html-italic">p</span> &lt; 0.05, vs. control.</p>
Full article ">Figure 4
<p>Quantification of mRNA expression related to OC-genesis (<b>A</b>) and NFATc1 induction (<b>B</b>,<b>C</b>) when adding S-PRG eluate. Results were presented as the means ± SD. *: <span class="html-italic">p</span> &lt; 0.05, vs. control.</p>
Full article ">Figure 5
<p>Phosphorylation of MAPK proteins (<b>A</b>,<b>B</b>) and the expression of total IκBα (<b>C</b>,<b>D</b>) by adding RANKL and S-PRG eluate. Results were presented as the means ± SD. *: <span class="html-italic">p</span> &lt; 0.05, vs. control.</p>
Full article ">Figure 6
<p>MAPK inhibitors suppressed the OC-genesis. The inhibitors against ERK, p38, and JNK significantly decreased the number of TRAP-positive cells (<b>A</b>,<b>B</b>) and pit area (<b>C</b>,<b>D</b>). Scale bars indicate 100 µm. Results were presented as the means ± SD. *: <span class="html-italic">p</span> &lt; 0.05, vs. control.</p>
Full article ">Figure 7
<p>S-PRG eluate, in combination with MAPK inhibitors, suppressed the OC-genesis. The addition of S-PRG elute to inhibitors against ERK, p38, and JNK adding to S-PRG eluate significantly decreased the number of TRAP-positive cells. Results were presented as the means ± SD. Scale bars indicate 100 µm. *: <span class="html-italic">p</span> &lt; 0.05, vs. control.</p>
Full article ">Figure 8
<p>Evaluation of the number of TRAP-positive cells (<b>A</b>,<b>B</b>) when adding S-PRG eluate released from HA. Scale bars indicate 100 µm. Results were presented as the means ± SD. *: <span class="html-italic">p</span> &lt; 0.05, vs. control.</p>
Full article ">Figure 9
<p>Each ion present in S-PRG eluate inhibited RANKL-induced OC-genesis. Sr<sup>2+</sup>, Al<sup>3+</sup>, F<sup>−</sup>, and B<sup>3+</sup> significantly decreased the number of TRAP-positive cells induced in Raw264.7 cells stimulated with RANKL (<b>A</b>,<b>B</b>). Pit area created by Raw264.7 cells incubated with Sr<sup>2+</sup>, F<sup>−</sup>, and B<sup>3+</sup> in the presence of RANKL was smaller than that in control (<b>C</b>,<b>D</b>). Scale bars indicate 100 µm. Results were presented as the means ± SD. *: <span class="html-italic">p</span> &lt; 0.05, vs. control.</p>
Full article ">Figure 10
<p>Potential effect of S-PRG eluate on periodontal disease. S-PRG eluate downregulates OC-genesis, as well as anti-inflammatory activity and antimicrobial activity.</p>
Full article ">
11 pages, 645 KiB  
Article
Migration Challenges and Their Impact on the Primary Healthcare System—A Qualitative Research
by Olga Partyka, Monika Pajewska, Aleksandra Czerw, Katarzyna Sygit, Oleh Lyubinets, Tomasz Banaś, Krzysztof Małecki, Elżbieta Grochans, Szymon Grochans, Anna Cybulska, Daria Schneider-Matyka, Elżbieta Cipora, Mateusz Kaczmarski, Krzysztof Sośnicki, Grażyna Dykowska, Zofia Sienkiewicz, Łukasz Strzępek, Ewa Bandurska, Weronika Ciećko, Jarosław Drobnik, Piotr Pobrotyn, Aleksandra Sierocka, Michał Marczak and Remigiusz Kozlowskiadd Show full author list remove Hide full author list
Healthcare 2024, 12(16), 1607; https://doi.org/10.3390/healthcare12161607 (registering DOI) - 12 Aug 2024
Abstract
In 2020 it is estimated that 281 million people were international migrants. Migrants constitute a potentially vulnerable population in terms of facing discrimination, poor living and housing conditions, and insufficient access to healthcare services. Due to the armed conflict in Ukraine in 2022, [...] Read more.
In 2020 it is estimated that 281 million people were international migrants. Migrants constitute a potentially vulnerable population in terms of facing discrimination, poor living and housing conditions, and insufficient access to healthcare services. Due to the armed conflict in Ukraine in 2022, almost 10 million people crossed the Polish border within a year of the outbreak of the conflict. The objective of this paper is to present the use of primary healthcare services by people migrating from Ukraine to Poland and identify the barriers in access to healthcare by this group of persons. This study used a qualitative research technique in the form of an expert interview using individual in-depth interviews (IDI). The study group consisted of professionally active primary healthcare providers (doctors, nurses, and facility managers) in Poland. Research was carried out in the areas regarding the availability of healthcare, the potential threats and challenges, and possible system solutions. The results showed that the most common cause for doctor’s appointments among migrants are respiratory infections, including COVID-19. Many cases were related to back pain, mainly resulting from the physical work of the patients. Additionally, some barriers to access and the provision of healthcare services for patients from Ukraine were identified. The majority (75%) of respondents indicated language as a significant barrier when providing services. Based on the study results, we recommend creating a dedicated website and telephone hotline for this group of persons as well as the use of traditional media to distribute information about access to healthcare services. It is also essential to focus on assistance for older people, since they may experience more difficulties with language and navigating the healthcare system. Full article
Show Figures

Figure 1

Figure 1
<p>Challenges, barriers, and methods of using services by patients from Ukraine based on the authors’ research of healthcare providers.</p>
Full article ">
14 pages, 1331 KiB  
Systematic Review
Fistulizing Perianal Disease as a First Manifestation of Crohn’s Disease: A Systematic Review and Meta-Analysis
by Liesbeth Jozefien Munster, Giulia Louise Emilia Mönnink, Susan van Dieren, Marco William Mundt, Geert Renaat Alfons Maria D’Haens, Willem Adrianus Bemelman, Christianne Johanna Buskens and Jarmila Dagmara Wendelien van der Bilt
J. Clin. Med. 2024, 13(16), 4734; https://doi.org/10.3390/jcm13164734 (registering DOI) - 12 Aug 2024
Abstract
Background: Incidences of perianal fistulas (PAFs) as a first manifestation of Crohn’s disease (CD) vary widely in the literature. Aim: To analyse the percentage of patients with a PAF preceding CD diagnosis and assess the time to diagnosis. Methods: A systematic [...] Read more.
Background: Incidences of perianal fistulas (PAFs) as a first manifestation of Crohn’s disease (CD) vary widely in the literature. Aim: To analyse the percentage of patients with a PAF preceding CD diagnosis and assess the time to diagnosis. Methods: A systematic literature search was conducted. Studies reporting on patients with a PAF preceding CD diagnosis were identified. Primary outcomes were the (weighted) percentage of patients with CD with a PAF preceding CD and their time to CD diagnosis. Secondary outcomes were the (weighted) percentage of patients with CD with a PAF preceding CD diagnosis in predefined patient subgroups, including (1) sex (men vs. women), (2) ethnicity (Asian vs. non-Asian), and (3) age (paediatric (0–18 y) and patients with elderly onset CD (>60 y) vs. adult patients (18–60 y)). Results: Seventeen studies were included (34,030 patients with CD). In the overall CD population, a PAF preceded CD in 8.6% [95%CI; 5.72; 12.71] with a weighted mean time to CD diagnosis of 45.9 (31.3) months. No studies reported details on sex differences in patients with a PAF as a manifesting sign of CD. In Asian populations, a PAF preceded CD in 17.66% [95%CI; 11.45; 26.25], which was significantly higher when compared with non-Asians (4.99% [95%CI; 3.75; 6.60], OR:3.99, p < 0.0001). In adolescents, an incidence of 9.17% [95%CI; 5.92; 13.93] was found with significantly lower incidences in paediatric patients (6.38% [95%CI; 1.84; 19.85], OR:0.53, p < 0.0001), and elderly-onset patients (3.77% [95%CI; 1.68; 8.25], OR:0.44, p = 0.0035). Conclusions: This systematic review shows that in the literature, almost 10% of patients present with a PAF as a first manifestation of CD, with a mean time to diagnosis of almost four years. These results emphasise that increased clinical awareness is needed. Full article
Show Figures

Figure 1

Figure 1
<p>Study selection process according to PRISMA guidelines [<a href="#B23-jcm-13-04734" class="html-bibr">23</a>].</p>
Full article ">Figure 2
<p>Forest plot on the weighted mean percentage of PAF first in patients with CD [<a href="#B29-jcm-13-04734" class="html-bibr">29</a>,<a href="#B30-jcm-13-04734" class="html-bibr">30</a>,<a href="#B31-jcm-13-04734" class="html-bibr">31</a>,<a href="#B32-jcm-13-04734" class="html-bibr">32</a>,<a href="#B33-jcm-13-04734" class="html-bibr">33</a>,<a href="#B34-jcm-13-04734" class="html-bibr">34</a>,<a href="#B35-jcm-13-04734" class="html-bibr">35</a>,<a href="#B36-jcm-13-04734" class="html-bibr">36</a>,<a href="#B37-jcm-13-04734" class="html-bibr">37</a>,<a href="#B38-jcm-13-04734" class="html-bibr">38</a>,<a href="#B39-jcm-13-04734" class="html-bibr">39</a>,<a href="#B40-jcm-13-04734" class="html-bibr">40</a>,<a href="#B41-jcm-13-04734" class="html-bibr">41</a>,<a href="#B42-jcm-13-04734" class="html-bibr">42</a>,<a href="#B43-jcm-13-04734" class="html-bibr">43</a>,<a href="#B44-jcm-13-04734" class="html-bibr">44</a>,<a href="#B45-jcm-13-04734" class="html-bibr">45</a>]. PAF = perianal fistula; CD = Crohn’s disease; CI = confidence interval; <span class="html-italic">p</span> = significance.</p>
Full article ">Figure 3
<p>(<b>a</b>) Forest plot on the weighted percentage of PAF first in patients with CD in Asian cohort studies [<a href="#B30-jcm-13-04734" class="html-bibr">30</a>,<a href="#B35-jcm-13-04734" class="html-bibr">35</a>,<a href="#B36-jcm-13-04734" class="html-bibr">36</a>,<a href="#B40-jcm-13-04734" class="html-bibr">40</a>,<a href="#B42-jcm-13-04734" class="html-bibr">42</a>,<a href="#B44-jcm-13-04734" class="html-bibr">44</a>,<a href="#B45-jcm-13-04734" class="html-bibr">45</a>]. PAF = perianal fistula; CD = Crohn’s disease; CI = confidence interval; <span class="html-italic">p</span> = significance. (<b>b</b>) Forest plot on the weighted percentage of PAF first in patients with CD in non-Asian cohort studies (reference group) [<a href="#B29-jcm-13-04734" class="html-bibr">29</a>,<a href="#B31-jcm-13-04734" class="html-bibr">31</a>,<a href="#B32-jcm-13-04734" class="html-bibr">32</a>,<a href="#B33-jcm-13-04734" class="html-bibr">33</a>,<a href="#B34-jcm-13-04734" class="html-bibr">34</a>,<a href="#B37-jcm-13-04734" class="html-bibr">37</a>,<a href="#B38-jcm-13-04734" class="html-bibr">38</a>,<a href="#B39-jcm-13-04734" class="html-bibr">39</a>,<a href="#B41-jcm-13-04734" class="html-bibr">41</a>,<a href="#B43-jcm-13-04734" class="html-bibr">43</a>]. PAF = perianal fistula; CD = Crohn’s disease; CI = confidence interval; <span class="html-italic">p</span> = significance.</p>
Full article ">Figure 4
<p>(<b>a</b>) Forest plot on the weighted percentage of PAF first in paediatric patients [<a href="#B29-jcm-13-04734" class="html-bibr">29</a>,<a href="#B32-jcm-13-04734" class="html-bibr">32</a>,<a href="#B35-jcm-13-04734" class="html-bibr">35</a>]. PAF = perianal fistula; CD = Crohn’s disease; CI = confidence interval; <span class="html-italic">p</span> = significance. (<b>b</b>) Forest plot on the weighted percentage of PAF first in patients 18–60 years (reference group) [<a href="#B29-jcm-13-04734" class="html-bibr">29</a>,<a href="#B30-jcm-13-04734" class="html-bibr">30</a>,<a href="#B33-jcm-13-04734" class="html-bibr">33</a>,<a href="#B34-jcm-13-04734" class="html-bibr">34</a>,<a href="#B36-jcm-13-04734" class="html-bibr">36</a>,<a href="#B37-jcm-13-04734" class="html-bibr">37</a>,<a href="#B38-jcm-13-04734" class="html-bibr">38</a>,<a href="#B39-jcm-13-04734" class="html-bibr">39</a>,<a href="#B40-jcm-13-04734" class="html-bibr">40</a>,<a href="#B41-jcm-13-04734" class="html-bibr">41</a>,<a href="#B42-jcm-13-04734" class="html-bibr">42</a>,<a href="#B43-jcm-13-04734" class="html-bibr">43</a>,<a href="#B44-jcm-13-04734" class="html-bibr">44</a>,<a href="#B45-jcm-13-04734" class="html-bibr">45</a>]. PAF = perianal fistula; CD = Crohn’s disease; CI = confidence interval; <span class="html-italic">p</span> = significance. (<b>c</b>) Forest plot on the weighted percentage of PAF first in patients with elderly-onset CD (&gt;60 years) [<a href="#B31-jcm-13-04734" class="html-bibr">31</a>,<a href="#B40-jcm-13-04734" class="html-bibr">40</a>]. PAF = perianal fistula; CD = Crohn’s disease; CI = confidence interval; <span class="html-italic">p</span> = significance.</p>
Full article ">
7 pages, 3210 KiB  
Case Report
Omentoplasty for Cervical Lymphocele after Aortic Arch Replacement
by Nora Hertel, Khaled Dastagir, Moritz Schmelzle, Linda Feldbrügge, Florian Helms, Peter M. Vogt, Arjang Ruhparwar and Aron-Frederik Popov
J. Clin. Med. 2024, 13(16), 4737; https://doi.org/10.3390/jcm13164737 (registering DOI) - 12 Aug 2024
Abstract
Lymphocele formation is a rare complication after surgical procedures involving the mediastinum. While uncomplicated lymphoceles show high rates of spontaneous closure and are usually treated conservatively, surgical treatment might be required in cases with persistent or recurrent lymphoceles. We present the case of [...] Read more.
Lymphocele formation is a rare complication after surgical procedures involving the mediastinum. While uncomplicated lymphoceles show high rates of spontaneous closure and are usually treated conservatively, surgical treatment might be required in cases with persistent or recurrent lymphoceles. We present the case of a 53-year-old male with reoccurring cervical swelling after two surgeries of the thoracic aorta. After 1.5 years, the swelling occurred for the first time and appeared for the next 2 years repeatedly without clinical or laboratory signs of infection. A cervical lymphocele was suspected, and the decision for surgical revision was made. Fibrin glue was applied to the potential leakage of the thoracic duct, and the cavity was filled with a free omental flap. This resulted in a complete regression of the swelling. Full article
14 pages, 1534 KiB  
Article
CCL2 Predicts Survival in Patients with Inoperable Hepatocellular Carcinoma Undergoing Selective Internal Radiotherapy
by Florian Haag, Severin Gylstorff, Jasmin Bujok, Maciej Pech and Borna Relja
Cancers 2024, 16(16), 2832; https://doi.org/10.3390/cancers16162832 (registering DOI) - 12 Aug 2024
Abstract
Purpose: Hepatocellular carcinoma (HCC) is the largest subgroup of primary liver tumors. Ablative therapies, such as selective internal radiation therapy (SIRT), are used in late stages for patients with unresectable liver metastases and no response to other therapies. CCL2 (C-C motif chemokine ligand [...] Read more.
Purpose: Hepatocellular carcinoma (HCC) is the largest subgroup of primary liver tumors. Ablative therapies, such as selective internal radiation therapy (SIRT), are used in late stages for patients with unresectable liver metastases and no response to other therapies. CCL2 (C-C motif chemokine ligand 2) is a potent monocyte chemoattractant. It is associated with tumor progression and metastasis. The role of circulating CCL2 as a biomarker in HCC undergoing selective internal radiation therapy remains unclear. Methods: A total of 41 patients (8 female, 33 male) suffering from HCC and undergoing SIRT were enrolled. Pre- and post-therapy changes in circulating CCL2 levels were determined by bead-based immunoassay and compared with clinical laboratory parameters and patient data. Results: A total of 32 patients exhibited survival beyond 60 days. It was observed that levels of CCL2 correlated with scores indicating a higher likelihood of non-survival and with the severity of the disease. Moreover, a significant inverse correlation was discovered between CCL2 levels and the survival of patients over 60 days in relation to counts of leukocytes, granulocytes, monocytes, and C-reactive protein. Conclusions: CCL2 may serve as a potential marker for patient survival after SIRT. The prediction of which HCC patients are likely to benefit from SIRT may be helpful in guiding therapeutic management. Full article
(This article belongs to the Special Issue Radiology for Diagnosis and Treatment of Liver Cancer)
Show Figures

Figure 1

Figure 1
<p>Illustration of elective study design of CCL2 before and after internal radiation therapy (SIRT) (created with BioRender.com). (<b>Top</b>) CT scan of a patient with hepatocellular carcinoma (HCC) lesion before and after therapy. The tumor shows typical features such as early contrast enhancement, combined with wash-out in the evaluation phase at the application of 99mTc-MAA via an arterial catheter after isolation of arterial hepatic blood supply. (<b>Bottom</b>) CC chemokine ligand 2 (CCL2) and blood, as well as clinical parameters and standard laboratory parameters, were collected and quantified before (pre-T) and after (post-T) therapy.</p>
Full article ">Figure 2
<p>Immune cell distribution, levels of Alkaline phosphatase (ALP), and C-reactive protein (CRP) depending on tumor patients’ (TP) survival status before and after selective internal radiotherapy (pre-T and post-T). Counts of leukocytes in absolute cell numbers [Gpt/L] (<b>A</b>), neutrophil granulocytes in percentages [%] (<b>B</b>), absolute neutrophil numbers [Gpt/L] (<b>C</b>), immature granulocytes in % (<b>D</b>), absolute immature granulocytes numbers (<b>E</b>), monocytes in % (<b>F</b>), monocytes as absolute cell numbers (<b>G</b>), levels of ALP (<b>H</b>), and CRP (<b>I</b>) in survivors and non-survivors (ns) pre-T and post-T are shown. Data are presented as mean ± standard error of the mean. *: <span class="html-italic">p</span> &lt; 0.05 vs. indicated group.</p>
Full article ">Figure 3
<p>CC chemokine ligand 2 (CCL2) is associated with patient survival status, pre- and post-selective internal radiotherapy. (<b>A</b>) Levels of CCL2 in tumor patient (TP) survivors vs. non-survivors (ns) before (pre-T) and after therapy (post-T). (<b>B</b>) Negative correlation between CCL2 levels before therapy and 60 days survival. (<b>C</b>) Sensitivity and specificity assessment of the prognostic performance of pre-therapy CCL2 levels in the prediction of 60 days survival by receiver operating curve analysis. Data are presented as mean ± standard error of the mean. *: <span class="html-italic">p</span> &lt;0.05 vs. indicated group.</p>
Full article ">
17 pages, 5266 KiB  
Article
Intrapleural Fibrinolytic Interventions for Retained Hemothoraces in Rabbits
by Christian J. De Vera, Jincy Jacob, Krishna Sarva, Sunil Christudas, Rebekah L. Emerine, Jon M. Florence, Oluwaseyi Akiode, Tanvi V. Gorthy, Torry A. Tucker, Karan P. Singh, Ali O. Azghani, Andrey A. Komissarov, Galina Florova and Steven Idell
Int. J. Mol. Sci. 2024, 25(16), 8778; https://doi.org/10.3390/ijms25168778 (registering DOI) - 12 Aug 2024
Abstract
Bleeding within the pleural space may result in persistent clot formation called retained hemothorax (RH). RH is prone to organization, which compromises effective drainage, leading to lung restriction and dyspnea. Intrapleural fibrinolytic therapy is used to clear the persistent organizing clot in lieu [...] Read more.
Bleeding within the pleural space may result in persistent clot formation called retained hemothorax (RH). RH is prone to organization, which compromises effective drainage, leading to lung restriction and dyspnea. Intrapleural fibrinolytic therapy is used to clear the persistent organizing clot in lieu of surgery, but fibrinolysin selection, delivery strategies, and dosing have yet to be identified. We used a recently established rabbit model of RH to test whether intrapleural delivery of single-chain urokinase (scuPA) can most effectively clear RH. scuPA, or single-chain tissue plasminogen activator (sctPA), was delivered via thoracostomy tube on day 7 as either one or two doses 8 h apart. Pleural clot dissolution was assessed using transthoracic ultrasonography, chest computed tomography, two-dimensional and clot displacement measurements, and gross analysis. Two doses of scuPA (1 mg/kg) were more effective than a bolus dose of 2 mg/kg in resolving RH and facilitating drainage of pleural fluids (PF). Red blood cell counts in the PF of scuPA, or sctPA-treated rabbits were comparable, and no gross intrapleural hemorrhage was observed. Both fibrinolysins were equally effective in clearing clots and promoting pleural drainage. Biomarkers of inflammation and organization were likewise comparable in PF from both groups. The findings suggest that single-agent therapy may be effective in clearing RH; however, the clinical advantage of intrapleural scuPA remains to be established by future clinical trials. Full article
(This article belongs to the Special Issue Molecular Aspects of Haemorrhagic and Thrombotic Disorders)
Show Figures

Figure 1

Figure 1
<p>Schematic representation of the RH model development, treatment, and outcome evaluation. This figure was created using <a href="https://Biorender.com" target="_blank">https://Biorender.com</a>.</p>
Full article ">Figure 2
<p>Retained clot size evaluation after treatment with IPFT. (<b>A</b>) Representative sonographs demonstrate the presence of clot before (0) and after (24 h) treatment with PBS (negative control), bolus, or double injection of fibrinolytics. Gross images taken postmortem show the presence of retained clot (RC) and lung (L) in the pleural space. (<b>B</b>) Based on sonographic imaging and using the distance measurement tool (Logiq e, R10 v1.3, GE Healthcare, Chicago, IL, USA), we measured the 2D Clot area (cm<sup>2</sup>) in the pleural space of rabbits before (0 h) and after treatment (24 h) with either PBS, 2 mg/kg sctPA (Bolus or Double delivery), 2 mg/kg scuPA (Bolus or Double delivery), or 1 mg/kg scuPA (Double delivery). (<b>C</b>) Using the same raw data set, the percent decrease in clot size was calculated between 0 h and 24 h. (<b>D</b>) The clots were harvested postmortem and measured using volume displacement method as described in material and method section. Clot volume data for 2 mg/kg sctPA (Bolus) and scuPA (Bolus) have limited data points as clots were preserved in situ at the beginning of the project to visualize the clot–lung adherence via histology. Kruskal–Wallis test with Dunn’s multiple comparison test was used to determine statistical significance for all data sets. A <span class="html-italic">p</span> &lt; 0.05 was represented as *, <span class="html-italic">p</span> &lt; 0.01 as **, <span class="html-italic">p</span> &lt; 0.001 as ***, and **** as <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 3
<p>Evaluation of lung restriction and expansion via CT. (<b>A</b>) Representative CT images (coronal view) of the rabbit thorax before RH induction (baseline) and before and after drainage at 24 h post-treatment are shown. Rabbits treated with PBS failed to drain. Therefore, these rabbits did not undergo a post-drainage scan. (<b>B</b>) Total evacuated PFs were calculated by summing the PF volumes drained at 8 h and 24 h; moreover, failure to drain any PFs from the rabbits were assigned a value = 0. (<b>C</b>) Vivoquant Studio 3.0 was used to calculate the 3D rabbit lung volume (mm<sup>3</sup>) for each treatment group at baseline (before induction of RH), before drainage, and after drainage. The Kruskal–Wallis or Friedman test with Dunn’s multiple comparison test was used to determine the statistical significance between treatment groups. A <span class="html-italic">p</span> &lt; 0.05 was depicted as * and <span class="html-italic">p</span> &lt; 0.01 as **.</p>
Full article ">Figure 4
<p>Histological evaluation of the rabbit pleural lining after treatment with IPFT. (<b>A</b>) Injured lung tissue from each rabbit subject were stained with Hematoxylin and Eosin Stain (<b>A1</b>–<b>A4</b>) to visualize pleural thickening (black arrows, 1 mm scale) and Masson Trichrome Stain (<b>A5</b>–<b>A8</b>) to visualize the overexpression of collagen (blue lining, 1 mm scale) in the pleural lining. (<b>B</b>) Morphometry quantified the extent of pleural thickening from each rabbit treated either PBS, sctPA, or scuPA. The Kruskal–Wallis test with Dunn’s multiple comparison determined the statistical significance between treatment groups. A <span class="html-italic">p</span> &gt; 0.05 demonstrated no statistical significance (not shown).</p>
Full article ">Figure 5
<p>IPFT did not increase extravascular bleeding and WBC infiltration in RH PFs. Total red (RBCs, (<b>A</b>)) and white (WBCs, (<b>B</b>)) blood cells in the RH PFs were measured to determine whether IPFT increased extravascular bleeding and WBC infiltration. WBC differential staining and analyses (<b>C</b>–<b>G</b>) was performed on the treated RH PFs as previously performed [<a href="#B12-ijms-25-08778" class="html-bibr">12</a>,<a href="#B15-ijms-25-08778" class="html-bibr">15</a>]. The Kruskal–Wallis test with Dunn’s multiple comparison determined the statistical significance between treatment groups. A <span class="html-italic">p</span> &gt; 0.05 was not shown.</p>
Full article ">Figure 6
<p>Effects of IPFT on the inflammatory profile of rabbits with RH. IL-6 (<b>A</b>), IL-8 (<b>B</b>), TNF-α (<b>C</b>), and TGF-β (<b>D</b>) levels in the treated RH PFs were quantified by ELISA as previously described [<a href="#B12-ijms-25-08778" class="html-bibr">12</a>,<a href="#B15-ijms-25-08778" class="html-bibr">15</a>]. The Kruskal–Wallis test with Dunn’s multiple comparison determined the statistical significance between treatment groups. A <span class="html-italic">p</span> &lt; 0.05 was represented as * and <span class="html-italic">p</span> &lt; 0.001 as ***.</p>
Full article ">Figure 7
<p>Intrapleural levels of plasminogen activators (tPA and uPA) and PAI-1 during IPFT of RH model. Levels of active (<b>A</b>) and total PAI-1 (<b>B</b>) in the PFs at 24 h were measured using ELISA as previously described [<a href="#B12-ijms-25-08778" class="html-bibr">12</a>,<a href="#B15-ijms-25-08778" class="html-bibr">15</a>]. Levels of active (<b>C</b>) and total antigen (<b>D</b>) PA (human tPA or uPA) in the RH PFs collected at 8 h and 24 h after administration pf the human PAs were measured by ELISA. The Kruskal–Wallis test with Dunn’s multiple comparison determined the statistical significance between treatment groups. A <span class="html-italic">p</span> &lt; 0.01 was represented as **.</p>
Full article ">
16 pages, 1022 KiB  
Article
Twenty-Four Hour Glucose Profiles and Glycemic Variability during Intermittent Religious Dry Fasting and Time-Restricted Eating in Subjects Without Diabetes: A Preliminary Study
by Beeke Peters, Christina Laetitia Pappe, Daniela A. Koppold, Katharina Schipp, Bert Arnrich, Andreas Michalsen, Henrik Dommisch, Nico Steckhan and Olga Pivovarova-Ramich
Nutrients 2024, 16(16), 2663; https://doi.org/10.3390/nu16162663 - 12 Aug 2024
Abstract
Intermittent religious fasting increases the risk of hypo- and hyperglycemia in individuals with diabetes, but its impact on those without diabetes has been poorly investigated. The aim of this preliminary study was to examine the effects of religious Bahá’í fasting (BF) on glycemic [...] Read more.
Intermittent religious fasting increases the risk of hypo- and hyperglycemia in individuals with diabetes, but its impact on those without diabetes has been poorly investigated. The aim of this preliminary study was to examine the effects of religious Bahá’í fasting (BF) on glycemic control and variability and compare these effects with time-restricted eating (TRE). In a three-arm randomized controlled trial, 16 subjects without diabetes were assigned to a BF, TRE, or control group. Continuous glucose monitoring and food intake documentation were conducted before and during the 19 days of the intervention, and the 24 h mean glucose and glycemic variability indices were assessed. The BF and TRE groups, but not the control group, markedly reduced the daily eating window while maintaining macronutrient composition. Only the BF group decreased caloric intake (−677.8 ± 357.6 kcal, p = 0.013), body weight (−1.92 ± 0.95 kg, p = 0.011), and BMI (−0.65 ± 0.28 kg, p = 0.006). Higher maximum glucose values were observed during BF in the within-group (+ 1.41 ± 1.04, p = 0.039) and between-group comparisons (BF vs. control: p= 0.010; TRE vs. BF: p= 0.022). However, there were no alterations of the 24 h mean glucose, intra- and inter-day glycemic variability indices, or glucotypes in any group. The proportions of time above and below the range (70–180 mg/dL) remained unchanged. BF and TRE do not exhibit negative effects on glycemic control and variability in subjects without diabetes. Full article
(This article belongs to the Special Issue Dietary Strategies in Metabolic Disorders)
11 pages, 547 KiB  
Article
The Functional Assessment of the Shoulder in Water Polo Players with Surface Electromyography and Kinematic Analysis: A Pilot Study
by Francesco Sgrò, Andrea Demeco, Nicola Marotta, Giampiero Merati, Mario Lipoma, Antonio Ammendolia, Cosimo Costantino and Teresa Iona
Appl. Sci. 2024, 14(16), 7077; https://doi.org/10.3390/app14167077 (registering DOI) - 12 Aug 2024
Abstract
Scapular dyskinesia, glenohumeral internal rotation deficit, upper posterior labral anterior tears, and rotator cuff injuries are common in athletes who play “overhead” sports due to their repetitive excessive movements. The aims of this study are to propose a new protocol with kinematic analysis [...] Read more.
Scapular dyskinesia, glenohumeral internal rotation deficit, upper posterior labral anterior tears, and rotator cuff injuries are common in athletes who play “overhead” sports due to their repetitive excessive movements. The aims of this study are to propose a new protocol with kinematic analysis coupled with sEMG and to objectively analyze the effect of a specific prevention exercise protocol. Thirty-two subjects (age: 22 ± 4 years, height: 183 ± 3.2 cm, BMI: 23 ± 0.96 kg/m2), including sixteen healthy subjects (Group A) and sixteen male water polo athletes (Group B), underwent a three-dimensional motion analysis based on optoelectronic and sEMG systems. A functional evaluation was performed on Group A and Group B to assess the reliability of the operator-dependent tasks and collect a series of normative data, before starting the prevention protocol (T0) and after 8 weeks (T1). The athletes performed a specific exercise protocol to prevent shoulder injuries. In Group B, the movements of abduction (T0: 111° ± 24°; T1: 140° ± 13°) and extension (T0: 72°± 10°; T1: 84° ± 2.8°) of the glenohumeral joint and the scapulothoracic joint (T0: 33° ± 8.36°; T1: 40.5° ± 10.6°) significantly improved. A significant reduction (in %) in the maximum voluntary contraction (MCV) at T1 of the upper trapezius, teres minor, and pectoralis major was observed. This protocol provides objective data in a simple and reliable way for the functional assessment of the shoulder in water polo players during the sport season. Full article
(This article belongs to the Special Issue Sports Medicine: Latest Advances and Prospects)
17 pages, 1842 KiB  
Article
Assessing the Value of Imaging Data in Machine Learning Models to Predict Patient-Reported Outcome Measures in Knee Osteoarthritis Patients
by Abhinav Nair, M. Abdulhadi Alagha, Justin Cobb and Gareth Jones
Bioengineering 2024, 11(8), 824; https://doi.org/10.3390/bioengineering11080824 (registering DOI) - 12 Aug 2024
Abstract
Knee osteoarthritis (OA) affects over 650 million patients worldwide. Total knee replacement is aimed at end-stage OA to relieve symptoms of pain, stiffness and reduced mobility. However, the role of imaging modalities in monitoring symptomatic disease progression remains unclear. This study aimed to [...] Read more.
Knee osteoarthritis (OA) affects over 650 million patients worldwide. Total knee replacement is aimed at end-stage OA to relieve symptoms of pain, stiffness and reduced mobility. However, the role of imaging modalities in monitoring symptomatic disease progression remains unclear. This study aimed to compare machine learning (ML) models, with and without imaging features, in predicting the two-year Western Ontario and McMaster Universities Arthritis Index (WOMAC) score for knee OA patients. We included 2408 patients from the Osteoarthritis Initiative (OAI) database, with 629 patients from the Multicenter Osteoarthritis Study (MOST) database. The clinical dataset included 18 clinical features, while the imaging dataset contained an additional 10 imaging features. Minimal Clinically Important Difference (MCID) was set to 24, reflecting meaningful physical impairment. Clinical and imaging dataset models produced similar area under curve (AUC) scores, highlighting low differences in performance AUC < 0.025). For both clinical and imaging datasets, Gradient Boosting Machine (GBM) models performed the best in the external validation, with a clinically acceptable AUC of 0.734 (95% CI 0.687–0.781) and 0.747 (95% CI 0.701–0.792), respectively. The five features identified included educational background, family history of osteoarthritis, co-morbidities, use of osteoporosis medications and previous knee procedures. This is the first study to demonstrate that ML models achieve comparable performance with and without imaging features. Full article
13 pages, 897 KiB  
Article
Post-COVID Myocarditis in Patients with Primary Cardiomyopathies: Diagnosis, Clinical Course and Outcomes
by Olga Blagova, Yulia Lutokhina, Evgeniya Kogan, Polina Savina, Svetlana Aleksandrova and Elena Zaklyazminskaya
Genes 2024, 15(8), 1062; https://doi.org/10.3390/genes15081062 - 12 Aug 2024
Abstract
The aim of this study was to evaluate the clinical course and outcomes of post-COVID myocarditis in patients with cardiomyopathies (CMP). This case series includes 10 patients with different CMPs who had COVID-19 (seven men; 48.4 ± 11.4 yr.): left ventricular non-compaction (n [...] Read more.
The aim of this study was to evaluate the clinical course and outcomes of post-COVID myocarditis in patients with cardiomyopathies (CMP). This case series includes 10 patients with different CMPs who had COVID-19 (seven men; 48.4 ± 11.4 yr.): left ventricular non-compaction (n = 2), arrhythmogenic right ventricular CMP in combination with a heterozygous form of hemochromatosis (n = 1, HFE), restrictive CMP (n = 1, MyBPC3), laminopathy (n = 1, LMNA), dilated cardiomyopathy (n = 1, MYH7 + MyBPC3), Danon’s disease (n = 1, LAMP2) and AL cardiac amyloidosis (n = 3). Myocardial morphological examination with immunohistochemical staining and PCR for SARS-CoV-2 and cardiotropic viruses was performed in six patients, while cardiac MRI and anti-cardiac antibody titres were evaluated in all patients. Post-COVID lymphocytic myocarditis was confirmed morphologically in six patients (with LVNC, RCM, ARCV, Danon’s disease, and AL amyloidosis). Spike and nucleocapsid coronavirus proteins were detected in cell infiltrates, endothelium and cardiomyocytes in all biopsies; SARS-CoV-2 RNA was found in five out of six. In four patients, the diagnosis of myocarditis was based on MRI, high titres of anti-cardiac antibodies and clinical data. The mean time from COVID-19 to the diagnosis of myocarditis was 7 (5; 10.5) months. Myocarditis manifested with the onset/increase of arrhythmias and heart failure. Immunosuppressive therapy with corticosteroids was administered to six patients and led to an increase in ejection fraction and improvement of heart failure symptoms in five of them. CMPs are a favourable background for the development of post-COVID myocarditis. The onset or deterioration of heart failure and/or arrhythmias in patients with CMPs after COVID-19 requires the exclusion of myocarditis and, if present, the administration of immunosuppressive therapy. Full article
(This article belongs to the Section Genetic Diagnosis)
12 pages, 3579 KiB  
Article
Comparative Efficacy of Fractional CO2 Laser Combined with Topical Steroid Cream versus Solution for Post-Thyroidectomy Scar Treatment: A Prospective Study
by Ching-Ya Huang, Yuan-Hao Yen, Cen-Hung Lin, Yueh-Ju Tsai, Ko-Chien Lin, Hui-Ping Lin and Ching-Hua Hsieh
Healthcare 2024, 12(16), 1605; https://doi.org/10.3390/healthcare12161605 - 12 Aug 2024
Abstract
Backgrounds: Post-thyroidectomy scarring is a common illness impacting patient quality of life. Fractional carbon dioxide (CO2) lasers and topical steroids delivered via laser-assisted drug delivery (LADD) have shown potential for scar treatment. However, ideal steroid formulations (cream vs. solution) when combined [...] Read more.
Backgrounds: Post-thyroidectomy scarring is a common illness impacting patient quality of life. Fractional carbon dioxide (CO2) lasers and topical steroids delivered via laser-assisted drug delivery (LADD) have shown potential for scar treatment. However, ideal steroid formulations (cream vs. solution) when combined with laser therapy remain unclear. Methods: This study included 12 patients receiving fractional CO2 laser on post-thyroidectomy scars. After laser treatment, one scar half received topically applied steroid cream, while the other half received steroid solution. The Patient and Observer Scar Assessment Scale (POSAS) was used to measure the scar conditions at the time prior to the first treatment and one year later by the patients themselves and by the surgeon who did the laser treatment. Scar appearance was photographically assessed at baseline and 6 months post-treatment by four blinded evaluators using scales. Results: This study discovered a modest improvement in the appearance of post-thyroidectomy scars when combining fractional CO2 laser treatment with either topical steroid cream or solution. Patients and treating physicians examined the POSAS scores one year after treatment found significant improvements in all aspects of the scar conditions, with high efficacy and satisfaction levels reported by patients. Conclusions: Fractional CO2 laser combined with topical steroid delivery, either cream or solution form, significantly enhanced post-thyroidectomy scar appearance with modest effect and high patient satisfaction. This approach may represent a promising scar management strategy along with current scar treatment for the post-thyroidectomy scar. Full article
Show Figures

Figure 1

Figure 1
<p>A visual comparison of four representative patients (<b>A</b>–<b>H</b>) undergoing treatment for post-thyroidectomy scars before and six months after their initial treatment. The “C” indicates sides treated with steroid cream clobetasol propionate in the concentration of 0.05%, while “T” stands for treatment with steroid solution of triamcinolone acetonide.</p>
Full article ">Figure 2
<p>(<b>A</b>) The Patient and Observer Scar Assessment Scale (POSAS) measurement based on patient assessments of overall scar conditions before and one year after initial treatment. This measurement is based on a 0–10 scale, with 0 representing no change from normal skin and 10 indicating a large departure. Lower ratings indicated better results. (<b>B</b>) Patient-reported satisfaction, which included general comments on the treatment’s efficacy and satisfaction. These measurements were assessed on a scale of −10 to 10, with 10 indicating high satisfaction. * <span class="html-italic">p</span> &lt; 0.05 indicates significant difference.</p>
Full article ">Figure 3
<p>The outcome of the entire treatment. (<b>A</b>) The Patient and Observer Scar Assessment Scale (POSAS) measurement based on physician assessments of overall scar conditions before to and one year after initial treatment. This measurement is based on a 0–10 scale, with 0 representing no change from normal skin and 10 indicating a large departure. Lower ratings indicated better results. (<b>B</b>) Physician-reported overall scarring condition compared to surrounding normal skin on a 0–10 scale, with 0 representing no difference from normal skin and 10 indicating a severe divergence. Lower scores indicated a better scar condition. (<b>C</b>) Physician-reported overall scar improvement six months after initial treatment vs. pre-treatment condition, with scores ranging from 0 to 10 and 10 indicating the most improvement. The dots with different color represented given scores by different physician. Higher scores are preferable. * <span class="html-italic">p</span> &lt; 0.05 indicates significant difference.</p>
Full article ">Figure 4
<p>The outcomes were judged using photographs taken after 6 months of initiating treatment and compared to those taken before treatment to determine which side was better than the other. These physicians were blinded to the treatment regimens applied to both sides of the post-thyroidectomy scar. The dots with different color represented given scores by different physician.</p>
Full article ">
14 pages, 1006 KiB  
Review
Cholesterol Metabolism and Urinary System Tumors
by Songyuan Yang, Zehua Ye, Jinzhuo Ning, Peihan Wang, Xiangjun Zhou, Wei Li and Fan Cheng
Biomedicines 2024, 12(8), 1832; https://doi.org/10.3390/biomedicines12081832 - 12 Aug 2024
Abstract
Cancers of the urinary system account for 13.1% of new cancer cases and 7.9% of cancer-related deaths. Of them, renal cancer, bladder cancer, and prostate cancer are most prevalent and pose a substantial threat to human health and the quality of life. Prostate [...] Read more.
Cancers of the urinary system account for 13.1% of new cancer cases and 7.9% of cancer-related deaths. Of them, renal cancer, bladder cancer, and prostate cancer are most prevalent and pose a substantial threat to human health and the quality of life. Prostate cancer is the most common malignant tumor in the male urinary system. It is the second most common type of malignant tumor in men, with lung cancer surpassing its incidence and mortality. Bladder cancer has one of the highest incidences and is sex-related, with men reporting a significantly higher incidence than women. Tumor development in the urinary system is associated with factors, such as smoking, obesity, high blood pressure, diet, occupational exposure, and genetics. The treatment strategies primarily involve surgery, radiation therapy, and chemotherapy. Cholesterol metabolism is a crucial physiological process associated with developing and progressing urinary system tumors. High cholesterol levels are closely associated with tumor occurrence, invasion, and metastasis. This warrants thoroughly investigating the role of cholesterol metabolism in urinary system tumors and identifying novel treatment methods for the prevention, early diagnosis, targeted treatment, and drug resistance of urinary system tumors. Full article
(This article belongs to the Section Endocrinology and Metabolism Research)
11 pages, 1168 KiB  
Article
Long-Term Functional Outcomes Following Enzymatic Debridement of Deep Hand Burns Using Nexobrid®: A Retrospective Analysis
by Asja T. Malsagova, Amin El-Habbassi, Moritz Billner, Maresa Berns, Tamas Pueski, Karl J. Bodenschatz, Paul I. Heidekrueger and Denis Ehrl
J. Clin. Med. 2024, 13(16), 4729; https://doi.org/10.3390/jcm13164729 (registering DOI) - 12 Aug 2024
Abstract
Background: For years, surgical debridement with autografting has been considered the standard of care in the treatment of severe burns of the hand. However, in recent years, enzymatic debridement has increasingly been reported as a good alternative, especially for burns of the [...] Read more.
Background: For years, surgical debridement with autografting has been considered the standard of care in the treatment of severe burns of the hand. However, in recent years, enzymatic debridement has increasingly been reported as a good alternative, especially for burns of the hand, as it selectively preserves viable tissue. In this study, we aim to evaluate the long-term function of the hand after enzymatic debridement in deep dermal burns. Methods: A retrospective chart review was conducted as well as measurements of subjective and objective outcome measures through physical examination and Disabilities of the Arm, Shoulder, and Hand (DASH), Patient and Observer Scar Assessment Scale (POSAS), and Vancouver Scar Scale (VSS) scores. Results: A total of 32 enzymatically debrided hands of 24 patients were included with a mean age of 42.4 ± 16.8 years and a mean follow-up of 31 months. Postoperatively, 19 of these could be managed conservatively using skin substitutes such as “Suprathel”, 13 had to undergo subsequent autografting. The mean DASH score for the entire study population was eight with a mean value of four in the conservatively managed group and fourteen in the autografted group. The mean Patient, Observer POSAS, and VSS values were nineteen, thirteen, and two. A total of 30 cases showed an effortless complete fist closure, and, also in 30 cases, patients attested to be satisfied with the esthetic appearance of the hand on being asked. Conclusions: The descriptive analysis of these results in our study population suggests that the enzymatic debridement of deep burns of the hand, especially combined with subsequent conservative management with skin substitutes, was associated with low long-term hand disability scores at a follow-up of two years. Full article
(This article belongs to the Special Issue Advancements in Individualized Plastic and Reconstructive Surgery)
Show Figures

Figure 1

Figure 1
<p>Flowchart of patients.</p>
Full article ">Figure 2
<p>Boxplots for the Disabilities of the Arm, Shoulder, and Hand (DASH) score distribution of the conservatively and surgically treated groups following enzymatic debridement. The dot in the middle of the figure is an outlier value. The normal DASH score has been reported to be around 10 in a general population study [<a href="#B24-jcm-13-04729" class="html-bibr">24</a>]. The following cut-off values for the DASH score have been described: &lt;15 corresponds with “no problem”, 16–40 with “problem, but working”, &gt;40 with “unable to work” [<a href="#B25-jcm-13-04729" class="html-bibr">25</a>].</p>
Full article ">Figure 3
<p>Boxplots for the Patient (<b>a</b>) and Observer (<b>b</b>) Scar Assessment Scale (POSAS) of the conservatively and surgically treated groups following enzymatic debridement. The dots represent outlier values.</p>
Full article ">Figure 4
<p>Boxplots for the handgrip strength of the conservatively and surgically treated groups following enzymatic debridement.</p>
Full article ">
12 pages, 681 KiB  
Article
The Risk Factors for Myopia Undercorrection in Second-Generation (Visumax 800) Keratorefractive Lenticule Extraction Surgery: A Retrospective Case–Control Study
by Chia-Yi Lee, Shun-Fa Yang, Hung-Chi Chen, Ie-Bin Lian, Chin-Te Huang, Jing-Yang Huang and Chao-Kai Chang
Diagnostics 2024, 14(16), 1752; https://doi.org/10.3390/diagnostics14161752 - 12 Aug 2024
Abstract
In this study, we aim to evaluate the risk factors of myopia undercorrection in recipients of second-generation keratorefractive lenticule extraction (KLEx) surgery. A retrospective case–control study was performed, and patients who received second-generation KLEx surgery were enrolled. The cases with myopia undercorrection were [...] Read more.
In this study, we aim to evaluate the risk factors of myopia undercorrection in recipients of second-generation keratorefractive lenticule extraction (KLEx) surgery. A retrospective case–control study was performed, and patients who received second-generation KLEx surgery were enrolled. The cases with myopia undercorrection were matched to non-myopia undercorrection cases with a 1:4 ratio according to age, and a total of 22 and 88 eyes were categorized into the undercorrection and control groups, respectively. Demographic, refractive, topographic, and surgical data were collected preoperatively. A generalized linear model was operated to evaluate the potential risk factors for myopia undercorrection. The uncorrected distance visual acuity (UDVA) at three months postoperation was significantly better in the control group (p = 0.006), and residual myopia and SE were significantly higher in the undercorrection group during the whole follow-up period (all p < 0.001). The UDVA value showed a trend of improvement in the control group (p < 0.001), and the changes to SE and residual myopia were significantly lower in the control group (both p < 0.001). Regarding the risk factors for myopia undercorrection in the whole population and the high-myopia population, a higher manifest sphere power, higher steep keratometry (K), higher topographic cylinder, lower central corneal thickness (CCT) at apex, higher CCT difference and lower residual stromal thickness (RST) correlated to myopia undercorrection (all p < 0.05). In the low-myopia population, only higher myopia and lower RST correlated to myopia undercorrection (both p < 0.05). In conclusion, a high-sphere power and irregular topographic pattern correlated to myopia undercorrection after the second KLEx surgery, especially for individuals with high myopia. Full article
(This article belongs to the Special Issue Eye Diseases: Diagnosis and Management—2nd Edition)
Show Figures

Figure 1

Figure 1
<p>The trend of uncorrected distance visual acuity changes in the two groups. UDVA: uncorrected distance visual acuity; * denotes significant differences in the trends of uncorrected distance visual acuity changes between the two groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 2
<p>The trend of spherical equivalent changes in the two groups. D: diopter and SE: spherical equivalent; * denotes significant differences in the trends of spherical equivalent changes between the two groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>The trend of sphere power changes in the two groups. D: diopter; * denotes significant differences in the trends of sphere power changes between the two groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
9 pages, 803 KiB  
Article
Influence of Health Insurance Coverage on the Survival Rate for Primary Total Knee Arthroplasty: Minimum 5-Year Follow-Up Analysis
by Jae-Sung Seo, Jung-Kwon Bae, Seong-Kee Shin, Hyung-Gon Ryu, Kyu Jin Kim and Seung Yeon Cho
Healthcare 2024, 12(16), 1601; https://doi.org/10.3390/healthcare12161601 - 12 Aug 2024
Abstract
This study investigated whether differences in survival rates and clinical outcomes exist in patients undergoing TKA by insurance type: National Health Insurance (NHI) vs. Medical Aid Program (MAP). This study conducted a retrospective analysis of 762 TKAs (NHI, n = 505; MAP, n [...] Read more.
This study investigated whether differences in survival rates and clinical outcomes exist in patients undergoing TKA by insurance type: National Health Insurance (NHI) vs. Medical Aid Program (MAP). This study conducted a retrospective analysis of 762 TKAs (NHI, n = 505; MAP, n = 257) with a mean follow-up of 8.4 ± 1.8 years. Patient-reported outcomes (PROMs) were evaluated using the American Knee Society’s (AKS) score at the final follow-up. The survival rate of each group was analyzed using Kaplan–Meier survival analysis. Any postoperative complications and readmissions within 90 days of discharge were recorded and compared between the groups. There were no between-group differences in pre- to postoperative improvement in AKS scores. The estimated 10-year survival rates were 98.5% in the NHI group and 96.9% in the MAP group, respectively, with no significant differences (p = 0.48). However, the length of hospital stay (LOS) was significantly longer in the MAP group than in the NHI group (13.4 days vs. 13.1 days, p = 0.03), and the transfer rate to other departments was significantly higher in the MAP group than in the NHI group (3.9% vs. 1.4%, p = 0.04). Readmission rates for orthopedic complications for 90 days were 3.0% in the NHI group and 3.5% in the MAP group, respectively (p = 0.67). Patients’ insurance type showed similar survival rates and clinical outcomes to those of primary TKA at a mean follow-up of 8.4 years, but the LOS and rate of transfer to other departments during hospitalization were influenced by insurance type. Full article
(This article belongs to the Special Issue Medicaid and Public Health: Second Edition)
Show Figures

Figure 1

Figure 1
<p>Flow diagram showing the number of knees that met the study criteria. NHI, National Health Insurance; MAP, Medical Aid Program.</p>
Full article ">Figure 2
<p>Kaplan–Meier analysis of cumulative survival for all-cause failure of NHI group and MAP group: (<b>A</b>) failure due to all complications; (<b>B</b>) septic failure (due to infection).</p>
Full article ">
Back to TopTop